References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
Nelson EB, McElroy SL. Psychotic depression. A guide to drug choice. CNS Drugs 1997 (Dec); 8 (6): 457–73
Johnson J, Horwarth E, Weissman MM. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry 1991; 48: 1075–81
Spiker DG, Weiss JC, Dealy RS, et al. The pharmacological treatment of delusional depression. Am J Psychiatry 1985; 142: 430–6
Bellini L, Gasperini M, Gatti F, et al. A double-blind study with fluvoxamine versus desipramine combined with placebo or haloperidol in delusional depression. In: Laeger SZ, Brunello N, Mendlewicz J, editors. Critical issues in the treatment of affective disorders. International Academy of Biomedical Drug Research; vol 9. Basel: Karger, 1994: 32–6
Parker G, Roy K, Hadzi-Pavlovic D, et al. Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord 1992; 24 (1): 17–24
Anton Jr RF, Burch Jr EA. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry 1990; 147 (9): 1204–8
Rothschild AJ, Bates KS, Boehringer KL et al. Olanzapine in psychotic depression. J Clin Psych 1999 (Feb); 60: 116–8
Aronson TA, Shukla S, Gujavarty K, et al. Relapse in delusional depression: a retrospective study of the course of treatment. Compr Psychiatry 1988; 29: 12–21
Rights and permissions
About this article
Cite this article
Diagnosis and treatment of psychotic depression remains a challenge. Drugs Ther. Perspect 15, 8–11 (2000). https://doi.org/10.2165/00042310-200015060-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200015060-00003